Skip to content

Effects of upregulation of CFAP206, RSPH4A, DNAH family in ciliary cells on the senescence process of endometrial cells

Effects of upregulation of CFAP206, RSPH4A, DNAH family in ciliary cells on the senescence process of endometrial cells

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083756
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thin endometrium

Interventions

A group:Endometrial organoids were grown from the endometrium of normal healthy women of childbearing age
B group:The CFAP206, RSPH4A, DNAH family of ciliated cells in thin endometrial organoids were upregulated after the organoids were cultured from endometrial tissue after abortion and uterine adhesion

Sponsors

Huazhong University of Science and Technology Union Shenzhen Hospictal
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Processing group: Women of childbearing age (18-35 years old), who have not used hormone therapy within the past month, are not patients with cycterial sac, have a history of abortion (B-ultrasonography indicates continuous interruption of intima) or thin intima without special reasons (B-ultrasonography indicates that the intima thickness of the middle luteum is < 7mm), have no other underlying diseases, no infectious diseases such as hepatitis B and AIDS, have informed and signed consent forms, and have a sexual life history. 2. Control group: women of reproductive age (18-35 years old), who have not used hormone therapy in the past month, who are not patients with occiliary sac, who have given birth or have no obvious abnormalities in endometrium indicated by B-ultrasound, and who have no other underlying diseases, who are informed and sign consent forms, and have a sexual life history.

Exclusion criteria

Exclusion criteria: Patients with poor compliance, acute or subacute pelvic infection, various vaginitis, active uterine bleeding (massive), recent history of uterine perforation or uterine repair, genital tuberculosis without appropriate anti-tuberculosis treatment, serious heart, lung, liver, kidney and other organ diseases, blood diseases, etc.

Design outcomes

Primary

MeasureTime frame
Endometrial organoid thickness;

Countries

China

Contacts

Public ContactLe Aiwen

Huazhong University of Science and Technology Union Shenzhen Hospital

leaiwen@126.com+86 180 3809 0785

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026